NCT06252571View on ClinicalTrials.gov

a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 7, 2024

Primary Completion Date

September 7, 2027

Study Completion Date

September 7, 2027

Conditions
Idiopathic Hypersomnia
Interventions
COMBINATION_PRODUCT

- Melatonin - Active light ttherapy

1 tablet per day, in the evening + morning light therapy over 6 weeks

COMBINATION_PRODUCT

- Placebo drug - Placebo light therapy

1 tablet per day in the evening + morning placebo light therapy

Trial Locations (1)

67000

RECRUITING

Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER